Biotechnology Stocks I Performance Guide: CymaBay Therapeutics, Inc. (CBAY)
CBAY has no dividends
Table and Chart of CBAY Performance
See what a $1,000 investment in CBAY is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| CBAY Returns | |
|---|---|
| Start Date | Mar-31-2014 |
| Start Price | $8.00 |
| End Date | Dec-01-2023 |
| End Price | $19.71 |
| # Prices | 118 |
| Min Date | Jan-29-2016 |
| Min Price | $1.09 |
| Max Date | Dec-01-2023 |
| Max Price | $19.71 |
| Total Return | 146.38% |
| Annualized Return | 9.60% |
| Current Value of $1,000 Purchase | $2,464 |
| Number Returns | 6,903 |
| Average Return | 92.75% |
| Number Profitable Returns | 3,795 |
| Percent Profitable Returns | 54.98% |
| Number Unprofitable Returns | 3,108 |
| Percent Unprofitable Returns | 45.02% |
| Profitable to Unprofitable Returns Ratio | 1.22 |
| CBAY Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,235,173,000 | Price to Sales | 72.07 |
| Earnings per Share | $-0.9300 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 6.85 |
| PRICE DATA | |
| 52 Week High | $19.88 |
| 52 Week Low | $3.83 |
| Analyst Target Price | $24.42 |
| 50-Day Moving Average | $15.84 |
| 200-Day Moving Average | $11.92 |
| FINANCIAL DATA | |
| Revenue per Share | $0.319 |
| Revenue | $31,016,000 |
| Profit Margin | -290.5% |
| Return on Equity | -0.466% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
CBAY Compare Returns with S&P 500
CBAY Trendline Chart